Episode 87 of TGen Talks features Dr. Haiyong Han, who dives into his latest work on one of the deadliest of cancers: pancreatic cancer.
He breaks down why this disease is so hard to catch early, how it can grow silently for years before symptoms appear, and why identifying true positives in general population is such a big challenge.
Dr. Han also shares promising progress toward a new non-invasive screening test that could one day enable earlier detection of pancreatic cancer. The goal? To turn this deadly disease into a more manageable condition, and give patients real hope for the future.
As we recognize Pancreatic Cancer Awareness Month in November, this episode emphasizes the urgent need for improved diagnostic methods, more effective treatments, and continued research to change the outcome for patients everywhere.
All content for TGen Talks is the property of TGen and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Episode 87 of TGen Talks features Dr. Haiyong Han, who dives into his latest work on one of the deadliest of cancers: pancreatic cancer.
He breaks down why this disease is so hard to catch early, how it can grow silently for years before symptoms appear, and why identifying true positives in general population is such a big challenge.
Dr. Han also shares promising progress toward a new non-invasive screening test that could one day enable earlier detection of pancreatic cancer. The goal? To turn this deadly disease into a more manageable condition, and give patients real hope for the future.
As we recognize Pancreatic Cancer Awareness Month in November, this episode emphasizes the urgent need for improved diagnostic methods, more effective treatments, and continued research to change the outcome for patients everywhere.
In this episode of TGen Talks, we sit down with three researchers who are working to make cancer care safer and more precise for some of the most vulnerable patients—children with rare brain tumors.
Dr. Floris Barthel, Dr. Shea Gallus, and graduate student Sharvari Mankame are part of a team at TGen and Phoenix Children’s Hospital exploring liquid biopsies—a method that uses small samples of blood or spinal fluid to detect and monitor brain cancer. This approach could reduce the need for invasive surgeries, which are especially hard on young patients.
Our guests explain how liquid biopsies work, what they’re learning from genetic markers called K-mers, and how artificial intelligence is helping them analyze tumor DNA in ways that weren’t possible before. Their goal is to find a better way to track cancer in real time—giving doctors more information while easing the burden on patients and families.
While this science is still developing, it’s already showing real potential to shift how we approach diagnosis and treatment—not just in pediatrics, but across cancer care.
TGen Talks
Episode 87 of TGen Talks features Dr. Haiyong Han, who dives into his latest work on one of the deadliest of cancers: pancreatic cancer.
He breaks down why this disease is so hard to catch early, how it can grow silently for years before symptoms appear, and why identifying true positives in general population is such a big challenge.
Dr. Han also shares promising progress toward a new non-invasive screening test that could one day enable earlier detection of pancreatic cancer. The goal? To turn this deadly disease into a more manageable condition, and give patients real hope for the future.
As we recognize Pancreatic Cancer Awareness Month in November, this episode emphasizes the urgent need for improved diagnostic methods, more effective treatments, and continued research to change the outcome for patients everywhere.
